| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1085007505 |
| P356 | DOI | 10.1038/SREP46750 |
| P932 | PMC publication ID | 5399448 |
| P698 | PubMed publication ID | 28429777 |
| P50 | author | Claudia Regina Cavaglieri | Q58370636 |
| Mara Patricia Traina Chacon-Mikahil | Q58370640 | ||
| Mirian A Kurauti | Q64495850 | ||
| P2093 | author name string | Antonio C Boschero | |
| Gustavo J Santos | |||
| Luiz F Rezende | |||
| Everardo M Carneiro | |||
| Sandra M Ferreira | |||
| Guilherme D Telles | |||
| Carlos H G Sponton | |||
| José M Costa-Júnior | |||
| P2860 | cites work | Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin | Q24299103 |
| Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway | Q24531184 | ||
| Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo | Q24683214 | ||
| Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin | Q27661904 | ||
| Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones | Q27683870 | ||
| Insulin degradation: progress and potential | Q28287093 | ||
| Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice | Q28537971 | ||
| STATs and gene regulation | Q29547796 | ||
| From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. | Q30361595 | ||
| Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study | Q30937160 | ||
| Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance | Q33939720 | ||
| Muscles, exercise and obesity: skeletal muscle as a secretory organ | Q34265667 | ||
| Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. | Q34857481 | ||
| Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus | Q35078223 | ||
| Improving patients' adherence to physical activity in diabetes mellitus: a review | Q35770020 | ||
| Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice | Q36087916 | ||
| Acute Exercise Improves Insulin Clearance and Increases the Expression of Insulin-Degrading Enzyme in the Liver and Skeletal Muscle of Swiss Mice | Q36088453 | ||
| IL-6: from its discovery to clinical applications | Q37735571 | ||
| Targeting gp130 to prevent inflammation and promote insulin action. | Q38134113 | ||
| Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease? | Q38869928 | ||
| Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway | Q39602224 | ||
| Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase | Q40227253 | ||
| Interleukin-6 induces cellular insulin resistance in hepatocytes | Q40687381 | ||
| Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats | Q40859035 | ||
| Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer's Disease. | Q41087317 | ||
| Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle | Q42135596 | ||
| Insulin metabolism in human adipocytes from subcutaneous and visceral depots | Q42841779 | ||
| IL-6 selectively stimulates fat metabolism in human skeletal muscle | Q42914691 | ||
| Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization | Q43064604 | ||
| Interleukin-6-deficient mice develop mature-onset obesity | Q43851625 | ||
| In VitroInhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters | Q44440518 | ||
| AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise | Q44953597 | ||
| Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction | Q44953893 | ||
| Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity | Q46233134 | ||
| Ciliary neurotrophic factor promotes survival of neonatal rat islets via the BCL-2 anti-apoptotic pathway | Q46970319 | ||
| Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing. | Q47744799 | ||
| Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death | Q48110123 | ||
| Serum Insulin Degrading Enzyme Level and Other Factors in Type 2 Diabetic Patients with Mild Cognitive Impairment. | Q50626513 | ||
| Acute exercise restores insulin clearance in diet-induced obese mice. | Q51287028 | ||
| The effects of a cafeteria diet on insulin production and clearance in rats. | Q51377992 | ||
| Exercise increases insulin clearance in healthy man and insulin-dependent diabetes mellitus patients. | Q51577817 | ||
| Attenuated PGC-1α Isoforms following Endurance Exercise with Blood Flow Restriction. | Q53111714 | ||
| Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle | Q58449836 | ||
| Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors | Q72564742 | ||
| Interleukin-6 stimulates gluconeogenesis in primary cultures of rat hepatocytes | Q72577466 | ||
| Evidence for genetic linkage of Alzheimer's disease to chromosome 10q | Q73316026 | ||
| Isolation of an insulin-degrading enzyme from beef liver | Q78556571 | ||
| Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis | Q79734930 | ||
| Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance | Q83473619 | ||
| Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice | Q83954187 | ||
| Exercise increases pancreatic β-cell viability in a model of type 1 diabetes through IL-6 signaling | Q86574238 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 46750 | |
| P577 | publication date | 2017-04-21 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Interleukin-6 increases the expression and activity of insulin-degrading enzyme | |
| P478 | volume | 7 |
| Q93033050 | Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues |
| Q89577731 | Exercise Training Rapidly Increases Hepatic Insulin Extraction in NAFLD |
| Q49199697 | Insulin-degrading enzyme is not secreted from cultured cells |
| Q92133757 | Modulation of liver glucose output by free or restricted feeding in the adult rat is independent of litter size |
| Q57173246 | Treadmill Exercise Ameliorates Spatial Learning and Memory Deficits Through Improving the Clearance of Peripheral and Central Amyloid-Beta Levels |
| Q90136344 | Whey protein sweetened with Stevia rebaudiana Bertoni (Bert.) increases mitochondrial biogenesis markers in the skeletal muscle of resistance-trained rats |
Search more.